Search Results 81-90 of 23130 for B cell lymphomas

  1. A Study of R-ICE and Lenalidomide for Treating Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma - Mayo Clinic

    Giving lenalidomide with R-ICE may be a better treatment for patients with diffuse large B-cell lymphoma. Participation eligibility. Participant eligibility ...

  2. A Study to Evaluate Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) - Mayo Clinic

    The purpose of tis study is to evaluate whether adding brentuximab vedotin helps two drugs work better to treat patients with diffuse large B-cell lymphoma ( ...

  3. Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma - Mayo Clinic

    ... Cell or Follicular B-Cell Lymphoma. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...

  4. Sorting Out T-Cell Lymphoma - Mayo Clinic News Network

    Although B cells and T cells can give rise to malignancies or lymphomas, T-cell lymphoma is the rarer disease, making up less than 15% of all Non-Hodgkin ...

  5. Chronic lymphocytic leukemia - Symptoms and causes - Mayo Clinic

    Monoclonal B-cell lymphocytosis (MBL) causes an increased number of a type of lymphocyte, called B lymphocytes, in the blood. ... B-cell lymphoma. This is ...

  6. Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas - Mayo Clinic

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...

  7. A Study to Compare the Effectiveness and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Transplant-eligible Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphomas - Mayo Clinic

    ... B-cell Non-Hodgkin Lymphomas. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information ...

  8. Advancement in CAR-T cell therapy for resistant B cell cancers - Mayo Clinic

    CAR -T cell therapy has shown potential in achieving remission in some B-cell lymphomas and leukemias. Yet, challenges persist with cancer relapsing in ...

  9. Doctors and departments - Mayo Clinic

    Research. Mayo Clinic doctors and researchers are studying diffuse large B-cell lymphoma to look for new ways to improve diagnosis and treatment for this cancer ...

  10. An Effectiveness and Safety Study of Daratumumab in Relapsed/Resistant Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular Lymphoma - Mayo Clinic

    Clinical Trials · An Effectiveness and Safety Study of Daratumumab in Relapsed/Resistant Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma, and Follicular ...